BioCentury
ARTICLE | Company News

X-Chem, X-Rx pharmaceuticals news

January 14, 2013 8:00 AM UTC

Newco X-Rx spun out of X-Chem. Rick Wagner, who is CEO of X-Rx, said the company will develop small molecule therapies against undisclosed "intractable" targets, with an initial focus on cancer and in...